Department of ENT, Prathima Relief Medical College, Warangal, India.
Head and Neck Services, Prathima Cancer Institute, Warangal, India.
Eur Arch Otorhinolaryngol. 2023 Nov;280(11):5091-5100. doi: 10.1007/s00405-023-08155-x. Epub 2023 Aug 7.
Oral cancer is one of the most common cancers among the Indian population. India bears the most burden of oral cancer globally. Impairment of swallowing function is often seen after treatment for oral cancer. The oral phase of swallowing is disrupted in patients undergoing resection for oral cancer. The primary purpose of this study was to evaluate the long-term swallowing outcomes of oral cancer patients using a patient-reported outcome questionnaire.
All consecutive oral cancer patients in the cT2-T4 category undergoing curative-intent surgery and reconstruction at our institute from March 2020 to March 2022 were included in the study. The Sydney Swallow questionnaire (SSQ) and functional oral intake scale (FOIS) assessed swallowing outcomes six months after definitive treatment. WHO BREF quality-of-life questionnaire was used to assess health-related quality of life.
A total of seventy patients with oral cancer were included. The median age was 49 years. The majority of them were males (90%). Tumors with cT4 constituted 62%; the rest, 48%, were cT2 and cT3 categories. The bulk of them were buccoalveolar tumors (64.3%. Almost two-thirds of the patients received multimodal treatment. Trismus and xerostomia were at 46% and 88%, respectively. The mean SSQ score was 257.4 ± 99.1. Swallowing outcomes are affected by T stage (p = 0.01), extent of resection (p = 0.01), multimodality treatment (p < 0.01), trismus (p = 0.05), and xerostomia (p = 0.01). Almost 69% of them required special food preparation for swallowing (FOIS 4&5). Patients with buccoalveolar disease (p = 0.05) had significantly poor quality of life.
An advanced stage with extensive resection and receiving multimodal treatment has adverse swallowing outcomes. Post-treatment trismus and xerostomia also significantly affected swallowing results.
口腔癌是印度人群中最常见的癌症之一。印度是全球口腔癌负担最重的国家。口腔癌治疗后常出现吞咽功能障碍。口腔癌患者在接受切除术后,其吞咽的口腔期受到干扰。本研究的主要目的是使用患者报告的结果问卷评估口腔癌患者的长期吞咽结果。
本研究纳入了 2020 年 3 月至 2022 年 3 月期间在我院接受根治性手术和重建的 cT2-T4 期连续口腔癌患者。悉尼吞咽问卷 (SSQ) 和功能性口腔摄入量表 (FOIS) 用于评估明确治疗后 6 个月的吞咽结果。世界卫生组织基本需求简表 (WHO BREF) 质量问卷用于评估健康相关生活质量。
共纳入 70 例口腔癌患者,中位年龄为 49 岁,大多数为男性 (90%)。T4 期肿瘤占 62%,其余 48%为 T2 和 T3 期。大部分为颊牙槽肿瘤 (64.3%)。近三分之二的患者接受了多模态治疗。张口困难和口干分别为 46%和 88%。SSQ 评分平均为 257.4±99.1。吞咽结果受 T 分期 (p=0.01)、切除范围 (p=0.01)、多模态治疗 (p<0.01)、张口困难 (p=0.05) 和口干 (p=0.01) 的影响。近 69%的患者需要特殊的吞咽准备食物 (FOIS 4&5)。患有颊牙槽疾病的患者 (p=0.05) 生活质量明显较差。
晚期、广泛切除和接受多模态治疗的患者吞咽结果不良。治疗后张口困难和口干也显著影响吞咽结果。